2018 ASCO Annual Meeting
The 2018 ASCO Annual Meeting, held June 1-5 in Chicago will be the platform for the release of thousands of scientific abstracts -- highly anticipated cancer research news for many people, including patients, caregivers, and the public. ASCO is pleased to share this timely information with the public in a variety of ways. On this page, you can find highlights of the scientific news program throughout the event.
Stay on top of news from ASCO scientific meetings, as well as articles, videos, podcasts, and events featured on Cancer.Net by signing up now to receive the free monthly newsletter Inside Cancer.Net. You can also follow Cancer.Net on Twitter, Facebook or Google+.
Wednesday, May 16
New Research from the ASCO Annual Meeting
Between June 1 and 5, oncology professionals from around the world will be at the ASCO Annual Meeting in Chicago, presenting and discussing the latest research in cancer treatment and patient care. This evening, some of the new research that will be presented at the Annual Meeting was released. Read patient-friendly summaries of several highlighted studies at Cancer.Net.
In one of the presented studies, a clinical trial of 357 people being treated for head and neck cancer found that those who used mobile and sensor technology daily to monitor their health had less severe general and cancer-related symptoms than those who received the usual care.
Additional research released today includes:
6 months of treatment with trastuzumab for HER2-positive breast cancer can be as effective and causes fewer heart problems than 12 months of treatment
New treatment schedules for T-cell leukemia and lymphoma lengthen the lives of younger patients
Most people who smoke heavily are not screened for lung cancer
Broad genetic testing may be a better choice for advanced lung cancer
Psychotherapy and acupuncture are effective for treating insomnia in cancer survivors